Breast cancer therapies, anthracyclines & trastuzumab can cause cardiotoxicity, but can cardiac rehab prevent heart damage? by Drs. Amy Kirkham, Edith Pituskin and DoM co-investigators Michael Stickland and Gavin Oudit share TITAN trial results on LVEF & lipid control. bit.ly/4hgRQkN
pmc.ncbi.nlm.nih.gov
TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast Cancer
Cardiac rehabilitation (CR) modeled care is recommended for patients with breast cancer to mitigate risk of cardiotoxicity. However, the cardiovascular impact of CR-modeled interventions has not been…